BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.69B |
| 2 |
Apple
AAPL
|
+$892M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
+$799M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$793M |
| 5 |
GE Aerospace
GE
|
+$748M |
Top Sells
| 1 |
Tesla
TSLA
|
+$362M |
| 2 |
Utilities Select Sector SPDR Fund
XLU
|
+$345M |
| 3 |
NVIDIA
NVDA
|
+$258M |
| 4 |
MetLife
MET
|
+$257M |
| 5 |
Meta Platforms (Facebook)
META
|
+$223M |
Sector Composition
| 1 | Technology | 26.74% |
| 2 | Consumer Discretionary | 11.23% |
| 3 | Financials | 10.63% |
| 4 | Healthcare | 8.41% |
| 5 | Communication Services | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SILA
3801
Sila Realty Trust, Inc.
SILA
$1.4B
| $12.2K | ﹤0.01% |
500
-34,029
| -99% | -$828K |
|
3802
Greenwich LifeSciences
GLSI
$156M
| $12.1K | ﹤0.01% |
+1,076
| New | +$12.1K |
|
3803
Acumen Pharmaceuticals
ABOS
$84.2M
| $12.1K | ﹤0.01% |
+7,017
| New | +$12.1K |
|
3804
Torrid Holdings
CURV
$191M
| $12K | ﹤0.01% |
+2,292
| New | +$12K |
|
3805
Traeger
COOK
$188M
| $12K | ﹤0.01% |
+5,005
| New | +$12K |
|
3806
Adverum Biotechnologies
ADVM
$65.9M
| $11.8K | ﹤0.01% |
2,537
-1,609
| -39% | -$7.51K |
|
|
CMMB
3807
Chemomab Therapeutics
CMMB
$15.8M
| $11.8K | ﹤0.01% |
+1,625
| New | +$11.8K |
|
3808
Lifeway Foods
LWAY
$499M
| $11.7K | ﹤0.01% |
473
-2,305
| -83% | -$57.2K |
|
|
SUNS
3809
Sunrise Realty Trust, Inc. Common Stock
SUNS
$150M
| $11.7K | ﹤0.01% |
831
-493
| -37% | -$6.94K |
|
3810
GrowGeneration
GRWG
$92.6M
| $11.7K | ﹤0.01% |
+6,920
| New | +$11.7K |
|
3811
Acrivon Therapeutics
ACRV
$48.8M
| $11.7K | ﹤0.01% |
+1,941
| New | +$11.7K |
|
3812
American Well
AMWL
$109M
| $11.6K | ﹤0.01% |
1,595
-8,419
| -84% | -$61K |
|
3813
Wallbox
WBX
$70.8M
| $11.4K | ﹤0.01% |
+1,137
| New | +$11.4K |
|
|
RGLS
3814
DELISTED
Regulus Therapeutics
RGLS
| $11.3K | ﹤0.01% |
+7,151
| New | +$11.3K |
|
3815
Tevogen Bio Holdings
TVGN
$174M
| $11.2K | ﹤0.01% |
10,908
-3,034
| -22% | -$3.13K |
|
|
SY
3816
So-Young International
SY
$378M
| $11.2K | ﹤0.01% |
13,500
+600
| +5% | +$498 |
|
3817
FiscalNote
NOTE
$73.3M
| $10.7K | ﹤0.01% |
+835
| New | +$10.7K |
|
3818
iShares S&P 100 ETF
OEF
$22.5B
| $10.7K | ﹤0.01% |
37
+33
| +825% | +$9.53K |
|
3819
Pembina Pipeline
PBA
$22.7B
| $10.5K | ﹤0.01% |
+284
| New | +$10.5K |
|
3820
Veru
VERU
$52.2M
| $10.4K | ﹤0.01% |
1,592
-3,510
| -69% | -$22.8K |
|
3821
GoHealth
GOCO
$77.7M
| $10.3K | ﹤0.01% |
+771
| New | +$10.3K |
|
3822
Offerpad Solutions
OPAD
$153M
| $10.3K | ﹤0.01% |
+3,600
| New | +$10.3K |
|
3823
374Water
SCWO
$58.9M
| $10.1K | ﹤0.01% |
+14,817
| New | +$10.1K |
|
3824
Werewolf Therapeutics
HOWL
$65.4M
| $10.1K | ﹤0.01% |
+6,832
| New | +$10.1K |
|
|
YRD
3825
Yiren Digital
YRD
$518M
| $10.1K | ﹤0.01% |
2,100
| – | – |
|